MarketCap
Facebook
X
Telegram
Puma Biotechnology PEG Ratio | PBYI
Annual PEG Ratio Puma Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.48 | -0.69 | -0.723 | -2.3 K | 0.0629 | 0.204 | -0.119 | -0.146 | -1.58 | 0.328 | 0.0975 | 0.3 | -1.47 | 0.0446 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.48 | -2.3 K | -164 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Lumos Pharma
LUMO
|
-0.00131 | - | - | $ 35.3 M |  USA |
 |
Syros Pharmaceuticals
SYRS
|
-0.00697 | - | -8.44 % | $ 3.4 M | USA |
 |
Gamida Cell Ltd.
GMDA
|
-0.0775 | - | -18.25 % | $ 5.04 M |  Israel |
 |
GT Biopharma
GTBP
|
-0.00067 | $ 4.5 | -7.02 % | $ 24.8 M | USA |
 |
Aravive
ARAV
|
-0.015 | - | -13.39 % | $ 1.45 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
0.181 | - | -74.18 % | $ 955 K | USA |
 |
C4 Therapeutics
CCCC
|
-0.601 | $ 2.96 | -5.29 % | $ 245 M | USA |
 |
Regeneron Pharmaceuticals
REGN
|
1.08 | $ 904.05 | -2.86 % | $ 94.6 B | USA |
 |
Codexis
CDXS
|
-0.174 | $ 1.02 | -5.56 % | $ 88.9 M | USA |
 |
Celldex Therapeutics
CLDX
|
1.27 | $ 28.24 | -5.65 % | $ 1.88 B | USA |
 |
CorMedix
CRMD
|
0 | $ 5.23 | -7.69 % | $ 377 K | USA |
 |
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 48.49 | -6.34 % | $ 4.36 B |  Schweiz |
 |
SIGA Technologies
SIGA
|
-4.14 | $ 2.98 | -5.56 % | $ 213 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Curis
CRIS
|
-0.00281 | $ 0.84 | -24.32 % | $ 11.1 M | USA |
 |
Champions Oncology
CSBR
|
0.854 | $ 4.79 | -0.83 % | $ 66.3 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
-0.000001 | $ 54.5 | -14.31 % | $ 6.55 M | USA |
 |
DiaMedica Therapeutics
DMAC
|
-14 | $ 9.03 | -16.16 % | $ 424 M | USA |
 |
Edesa Biotech
EDSA
|
-0.0227 | $ 2.14 | -1.38 % | $ 12.1 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-0.471 | $ 13.88 | -8.86 % | $ 898 M | USA |
 |
Evogene Ltd.
EVGN
|
-0.00649 | $ 0.32 | -9.87 % | $ 2.52 M | Israel |
 |
Exelixis
EXEL
|
-2.14 | $ 68.71 | -5.56 % | $ 18.7 B | USA |
 |
Xeris Pharmaceuticals
XERS
|
-26.7 | $ 13.16 | 25.76 % | $ 2.11 B | USA |
 |
Fennec Pharmaceuticals
FENC
|
0.000178 | $ 9.35 | -9.66 % | $ 267 M | USA |
 |
AbbVie
ABBV
|
21.1 | $ 288.16 | -2.26 % | $ 510 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 1.58 | -5.39 % | $ 2.6 M | Israel |
 |
vTv Therapeutics
VTVT
|
-76.9 | $ 21.86 | -9.03 % | $ 86.4 M | USA |
|
Forte Biosciences
FBRX
|
-0.00934 | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
AC Immune SA
ACIU
|
2.39 | $ 2.11 | -7.86 % | $ 213 M | Schweiz |
 |
Aldeyra Therapeutics
ALDX
|
1.65 | $ 0.61 | -5.56 % | $ 36.6 M | USA |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M |  Canada |
 |
AIM ImmunoTech
AIM
|
-0.000094 | $ 0.15 | -4.97 % | $ 243 K | USA |
 |
Ascendis Pharma A/S
ASND
|
4.41 | $ 252.45 | -2.12 % | $ 15.3 B |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
0.147 | $ 69.63 | -2.83 % | $ 1.4 B | USA |
 |
Actinium Pharmaceuticals
ATNM
|
0.175 | $ 1.31 | -7.09 % | $ 40.9 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.24 | -10.14 % | $ 330 M |  Britain |
 |
BridgeBio Pharma
BBIO
|
2.48 | $ 74.33 | -4.57 % | $ 14.2 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
-0.00258 | $ 7.51 | -8.92 % | $ 1.58 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-0.167 | $ 3.49 | -6.18 % | $ 242 M | Britain |
 |
Coherus BioSciences
CHRS
|
-0.0207 | $ 0.75 | -11.77 % | $ 87.9 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 27.01 | -20.69 % | $ 3.44 B | USA |
 |
Cellectis S.A.
CLLS
|
0.221 | $ 1.01 | -13.68 % | $ 101 M |  France |
 |
BeyondSpring
BYSI
|
2.09 | $ 0.65 | -4.9 % | $ 26.7 M | USA |
 |
Alkermes plc
ALKS
|
-0.493 | $ 44.51 | -3.01 % | $ 7.33 B |  Irlanda |
 |
Altimmune
ALT
|
0.647 | $ 1.97 | -7.31 % | $ 174 M | USA |
 |
Cardiff Oncology
CRDF
|
185 | $ 0.76 | -13.05 % | $ 50.8 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
-0.000437 | $ 0.55 | -0.07 % | $ 6.09 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 9.34 | -14.08 % | $ 256 M | Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
-141 | $ 57.46 | -6.8 % | $ 7.69 B | USA |
 |
Atara Biotherapeutics
ATRA
|
0.00555 | $ 8.04 | -3.94 % | $ 101 M | USA |